Back to search results

A Study to Evaluate the Safety and Efficacy of EscharEx (EX-02) in the Treatment of Basal Cell Carcinoma

Abroad (travel likely)RecruitingPHASE1, PHASE2

Conditions

Superficial Basal Cell Carcinoma · Nodular Basal Cell Carcinoma

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

  • Center for Clinical and Cosmetic Research, Aventura, Florida, United States

    Contact: Study coordinator (Brian Berman, MD)
    Contact: Principal Investigator (Brian Berman, MD)

  • Moore Clinical Research, Inc., Brandon, Florida, United States

    Contact: Study coordinator (Michael Bland, VP) · MBland@MoorCR.com · 813-948-7550
    Contact: Principal Investigator (Stanley N Katz, MD)

  • Center for Clinical Studies, LTD. LLP, Webster, Texas, United States

    Contact: Study coordinator (Stephen Tyring, MD) · styring@ccstexas.com · 281-333-2288
    Contact: Principal Investigator (Stephen Tyring, MD)
Study leads

  • Lior Rosenberg, Prof.

    Study Director

    MediWound Ltd

View source on ClinicalTrials.gov(opens in a new tab)